Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression.
about
Rapamycin blocks fibrocyte migration and attenuates bronchiolitis obliterans in a murine model.Inhibiting CXCL12 blocks fibrocyte migration and differentiation and attenuates bronchiolitis obliterans in a murine heterotopic tracheal transplant model.Immunosuppressive cyclosporin A activates AKT in keratinocytes through PTEN suppression: implications in skin carcinogenesis.Lung Transplantation for Lymphangioleiomyomatosis in Japan.Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients.Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelinesEmerging drugs in lung transplantation.Invasive fungal infections and antifungal therapies in solid organ transplant recipients.A Case of Successful Therapy by Intrapleural Injection of Fibrin Glue for Chylothorax after Lung Transplantation for Lymphangioleiomyomatosis.Proliferation signal inhibitor toxicities after thoracic transplantation.Immunosuppression in lung transplantation.Experience of Lung Transplantation in Patients with Lymphangioleiomyomatosis at a Brazilian Reference Centre.Growth hormone abolishes the negative effects of everolimus on intestinal wound healing.Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients.A new endoscopic standardized grading system for macroscopic central airway complications following lung transplantation: the MDS classification.Cystic Lung Disease in Genetic Syndromes with Deficient Tumor Suppressor Gene Function.Refractory intracranial hypertension in posterior reversible encephalopathy syndrome.Should mammalian target of rapamycin inhibitors be stopped in women with lymphangioleiomyomatosis awaiting lung transplantation?New frontiers in immunosuppression.A review on therapeutic drug monitoring of the mTOR class of immunosuppressants: everolimus and sirolimus
P2860
Q30409683-EDEACA8E-20C6-404A-B7E5-7B9EE2D4E024Q30414598-45A93F27-AB9B-49FA-AD09-28F15A6F12C3Q33799731-0F87D21D-8690-43EC-953D-9F3AC306CC00Q35895325-7CCC86B5-C13F-4DBC-B20E-3F1F850B3702Q36250851-B059850A-8F38-4E6F-A11C-AB19B3EF1888Q36724093-153EACBE-8E79-4E54-8C89-4FCA3871F006Q36758582-72F3AAFF-63F7-4C34-A11F-11C3AA348356Q36872848-34E5C937-BEFC-46FD-92EA-035867BE90FAQ37695850-3B91A809-49C2-4B16-BAA7-35867E9BBBC4Q38044748-CA3CB8F2-8FE2-48DB-A395-58B801766699Q38240865-9A0A9C6F-80C3-4E76-B681-0647876D7BB0Q38617379-D46983ED-3934-430E-95F6-10FE55BBCCFFQ40895259-AAE39CCD-EB5B-443B-876D-31CA874FC182Q45992631-0B3B4341-D311-4324-8A6B-F94691E94CEBQ46005407-696C5EED-3CE3-442F-83E5-EBD09207A39EQ47370738-781C7C64-D52B-4458-9E96-4D0B01F99857Q48006551-E88D6973-923E-4C7E-9B1A-CB5D10C05266Q53022016-29374904-D06C-4FA9-9744-9A242F6E28BEQ55547403-7F7C635F-720F-4A62-A85C-FD810273CA12Q56035477-D3BF2505-0658-4360-BC2B-8D0DF6CE72BC
P2860
Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Airway anastomosis complicatio ...... limus-based immunosuppression.
@en
Airway anastomosis complicatio ...... limus-based immunosuppression.
@nl
type
label
Airway anastomosis complicatio ...... limus-based immunosuppression.
@en
Airway anastomosis complicatio ...... limus-based immunosuppression.
@nl
prefLabel
Airway anastomosis complicatio ...... limus-based immunosuppression.
@en
Airway anastomosis complicatio ...... limus-based immunosuppression.
@nl
P2093
P1476
Airway anastomosis complicatio ...... limus-based immunosuppression.
@en
P2093
Bruno Meiser
Bruno Reichart
Fritz Spelsberg
Iris Bittmann
Jan Groetzner
Jurgen Behr
Lorenz Frey
Michael Vogeser
Munich Lung Transplant Group
P304
P356
10.1016/S1053-2498(03)00309-7
P577
2004-05-01T00:00:00Z